Related Experiment Video
Updated: Jan 2, 2026

Measuring Caspase Activity Using a Fluorometric Assay or Flow Cytometry
Published on: March 24, 2023
Implications of caspase-dependent proteolytic cleavage of cyclin A1 in DNA damage-induced cell death
Sang Hyeok Woo1, Sung-Keum Seo1, Sungkwan An2
1Division of Radiation Cancer Research, Korea Institute of Radiological & Medical Sciences, 215-4 Gongneung-dong, Nowon-gu, Seoul, Republic of Korea.
Abstract:
Cyclin A1 is an A-type cyclin that directly binds to CDK2 to regulate cell-cycle progression. In the present study, we found that doxorubicin decreased the expression of cyclin A1 at the protein level in A549 lung cancer cells, while markedly downregulating its mRNA levels. Interestingly, doxorubicin upregulated caspase-1 in a concentration-dependent manner, and z-YAVD-fmk, a specific inhibitor of caspase-1, reversed the doxorubicin-induced decrease in cyclin A1 in A549 lung cancer and MCF7 breast cancer cells. Active caspase-1 effectively cleaved cyclin A1 at D165 into two fragments, which in vitro cleavage assays showed were further cleaved by caspase-3. Finally, we found that overexpression of cyclin A1 significantly reduced the cytotoxicity of doxorubicin, and knockdown of cyclin A1 by RNA interference enhanced the sensitivity of cells to ionizing radiation. Our data suggest a new mechanism for the downregulation of cyclin A1 by DNA-damaging stimuli that could be intimately involved in the cell death induced by DNA damage-inducing stimuli, including doxorubicin and ionizing radiation.
Insights
Doxorubicin reduces cyclin A1 (cell cycle regulator) in lung cancer cells via caspase-1 activation. Restoring cyclin A1 levels protects cells from doxorubicin and radiation, revealing a new DNA damage response pathway.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Cyclin A1 regulates cell-cycle progression by binding to CDK2.
- Understanding cyclin A1's role in DNA damage response is crucial for cancer therapy.
Purpose of the Study:
- To investigate the effect of doxorubicin on cyclin A1 expression.
- To elucidate the mechanism of cyclin A1 regulation by DNA-damaging agents.
- To determine the role of cyclin A1 in cellular response to doxorubicin and ionizing radiation.
Main Methods:
- Western blotting and quantitative PCR to assess protein and mRNA levels.
- Enzyme inhibition assays using z-YAVD-fmk.
- In vitro cleavage assays with purified caspases.
- Cell viability assays and RNA interference for functional studies.
Main Results:
- Doxorubicin decreased both protein and mRNA levels of cyclin A1 in A549 lung cancer cells.
- Doxorubicin upregulated caspase-1, and its inhibition restored cyclin A1 levels.
- Active caspase-1 cleaved cyclin A1, with subsequent cleavage by caspase-3.
- Overexpression of cyclin A1 reduced doxorubicin cytotoxicity, while its knockdown increased sensitivity to ionizing radiation.
Conclusions:
- DNA-damaging agents like doxorubicin downregulate cyclin A1 through caspase-1 activation.
- Cyclin A1 plays a protective role against DNA damage-induced cell death.
- This pathway involving cyclin A1 and caspases is a novel mechanism in cellular response to DNA damage.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Caspases
Inhibition of Cdk Activity
The Intrinsic Apoptotic Pathway
Anaphase Promoting Complex

